Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs (original) (raw)

British Journal of Cancer volume 82, pages 966–972 (2000)Cite this article

This article has been updated

Abstract

Previous work has shown platinum drugs to differ in their effects on the peripheral nervous system. To test whether their differential toxicity was due to differences in their partitioning into the peripheral nervous system, we correlated the hydrophobicity, reactivity, tissue accumulation and neurotoxicity of a series of eight platinum analogues. Neurotoxicity was detected by measuring sensory nerve conduction velocity (SNCV) in Wistar rats treated twice per week at the maximum tolerated dose. Tissue platinum concentrations were measured by inductively coupled plasma mass spectrometry. Hydrophobicity (log P) was measured using an octanol-aqueous shake-flask method. The half-life of platinum drug binding to plasma proteins in vitro was determined. The cumulative dose causing altered SNCV ranged from 15 to > 2050 μmol kg–1. Ranking of the compounds by their neurotoxic potency in rats (oxaliplatin >R,R -(DACH)PtC4> ormaplatin >S,S -(DACH)PtCl4>S,S -(DACH)Pt oxalato > cisplatin > carboplatin > JM216) correlated with the frequency of neurotoxicity in patients (r_> 0.99;P< 0.05). Ranking the compounds by their peripheral nerve accumulation was cisplatin > carboplatin > oxaliplatin >R,R -(DACH)PtCl4≈_S,S -(DACH)PtCl4and did not correlate with neurotoxicity. Log P ranged from – 2.53 to –0.16 but did not correlate with neurotoxicity. Log P correlated inversely with platinum accumulation in dorsal root ganglia (r2= 0.99;P = 0.04), sural nerve (r2= 0.85;P = 0.025), sciatic nerve (r2= 0.98;P = 0.0012), spinal cord (r2= 0.97, P = 0.018) and brain (r2= 0.98, P = 0.001). Reactivity correlated with neurotoxicity potency in rats (r2= 0.89, P = 0.0005) and with the frequency of neurotoxicity in patients (r2= 0.99, P = 0.0002). The hydrophilicity of platinum drugs correlates with platinum sequestration in the peripheral nervous system but not with neurotoxicity. Differences in the reactivity of platinum complexes accounts for some of the variation in their neurotoxicity. © 2000 Cancer Research Campaign

Similar content being viewed by others

Article PDF

Change history

This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Private Bag 92019, Auckland, New Zealand
    D Screnci, M J McKeage & P Galettis
  2. School of Chemistry, University of Sydney, Sydney, NSW 2050, Australia
    T W Hambley
  3. Auckland Cancer Society Research Centre, School of Medicine, The University of Auckland, Private Bag 92019, Auckland, New Zealand
    B D Palmer & B C Baguley

Authors

  1. D Screnci
    You can also search for this author inPubMed Google Scholar
  2. M J McKeage
    You can also search for this author inPubMed Google Scholar
  3. P Galettis
    You can also search for this author inPubMed Google Scholar
  4. T W Hambley
    You can also search for this author inPubMed Google Scholar
  5. B D Palmer
    You can also search for this author inPubMed Google Scholar
  6. B C Baguley
    You can also search for this author inPubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Screnci, D., McKeage, M., Galettis, P. et al. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs.Br J Cancer 82, 966–972 (2000). https://doi.org/10.1054/bjoc.1999.1026

Download citation

Keywords